Shiga-ken, Japan

Norio Iwasawa


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Osaka, JP (1992)
  • Kyoto, JP (1992)
  • Shiga-ken, JP (2000)

Company Filing History:


Years Active: 1992-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Norio Iwasawa: Innovator in Therapeutics

Introduction

Norio Iwasawa is a prominent inventor based in Shiga-ken, Japan. He has made significant contributions to the field of therapeutics, particularly in the development of innovative treatments for various medical conditions. With a total of 3 patents to his name, Iwasawa continues to push the boundaries of scientific research and application.

Latest Patents

Iwasawa's latest patents include groundbreaking work on therapeutics for thrombocytopenia. His inventions encompass an enzyme inhibitor and a method of producing the same. Additionally, he has developed novel peptide analogues that exhibit inhibitory activity against aspartic proteinases. This work also involves a novel species of actinomycetous microorganism that produces these peptide analogues, along with a process for culturing this species to produce the analogues and a pharmaceutical composition containing them.

Career Highlights

Iwasawa is currently associated with Suntory Limited, a well-respected company known for its commitment to innovation and quality. His work at Suntory has allowed him to explore new frontiers in therapeutic development, contributing to the company's reputation as a leader in the industry.

Collaborations

Iwasawa has collaborated with notable colleagues, including Naoki Higuchi and Masayuki Saitoh. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Norio Iwasawa is a distinguished inventor whose work in therapeutics has the potential to make a significant impact on healthcare. His innovative patents and collaborations reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…